ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
About ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
31
Hoffmann-La Roche
13
Fondazione Italiana Linfomi ONLUS
6
Gruppo Italiano Trapianto di Midollo Osseo
5
Heart Care Foundation
3
Azienda Ospedaliera Universitaria Integrata Verona
2
Boehringer Ingelheim
2
European Organisation for Research and Treatment of Cancer - EORTC
2
Fondazione Italiana Sindromi Mielodisplastiche-ETS
2
Northern Italy Leukemia Group
2
Associazione Qol-one
1
Clinical Trials at ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
During the past decade, ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 12 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
2002-09-01
2012-02-01
Completed
472
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2001-09-01
Unknown status
700
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
2004-06-01
Unknown status
279
Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients
2001-09-01
2004-03-01
Completed
158
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
2006-09-04
2011-05-26
Completed
545
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
2004-10-01
2014-03-01
Completed
470
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 31 trials, followed by "Hoffmann-La Roche" with 13 trials
sponsored, "Fondazione Italiana Linfomi ONLUS" with 6 trials sponsored, "Gruppo Italiano Trapianto di Midollo Osseo" with 5 trials sponsored and "Heart Care Foundation"
with 5 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO"
#1 collaborator was "Agenzia Italiana del Farmaco" with 2 trials as a collaborator, "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
According to Clinical.Site data, the most researched conditions in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO" are
"Chronic Myeloid Leukemia" (6 trials), "Leukemia" (6 trials), "Multiple Sclerosis" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO" in a lesser frequency.
Clinical Trials Intervention Types at ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
Most popular intervention types in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO" are "Drug" (53 trials), "Other" (20 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (5 trials), "Obinutuzumab" (3 trials), "idarubicin" (3 trials) and "Bendamustine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
The vast majority of trials in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO" are
79 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO
Currently, there are NaN active trials in "ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO".
undefined are not yet recruiting,
11 are recruiting,
10 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 44 completed trials in ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, 1 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".